Healthcare

Archimed, KKR and Novo target medical genetics; untapped women’s health investments could generate $14bn in returns

Private equity bets on the pharma and life sciences sector.

17 January 2025•4 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.